Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes

NCT02752113 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

NETWORK

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Empagliflozin and Linagliptin
DRUG: Metformin and Insulin sc

Sponsor

Institut für Pharmakologie und Präventive Medizin

Collaborators

[object Object]